ARS Pharmaceuticals is a stealth pharmaceutical company that specializes in developing anti allergy drugs.
ARS Pharmaceuticals has raised $100.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in September 2025.
ARS Pharmaceuticals's investors include RA Capital Management, SR One, Deerfield, Ontario Municipal Employees Retirement System.
ARS Pharmaceuticals is headquartered in San Diego, United States.
ARS Pharmaceuticals is a stealth pharmaceutical company that specializes in developing anti allergy drugs.
ARS Pharmaceuticals is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ARS Pharmaceuticals — Funding & Investors." VCBacked, September 29, 2025, https://www.vcbacked.co/company/ars-pharmaceuticals. Accessed November 11, 2026.
VCBacked. (2025). ARS Pharmaceuticals — Funding & Investors. Retrieved November 11, 2026, from https://www.vcbacked.co/company/ars-pharmaceuticals
{{cite web |title=ARS Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/ars-pharmaceuticals |website=VCBacked |access-date=November 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at ARS Pharmaceuticals? Request a listing update